REDWOOD-HCM Cohort 3

REDWOOD-HCM Cohort 3: evidence for clinical efficacy of aficamten patients with obstructive HCM and HF symptoms refractory to maximal medical therapy, including disopyramide

Format

JPEG

Source

Cytokinetics, Incorporated

REDWOOD-HCM Cohort 3

Format

Source

Downloads